First gene therapy for Europe moves closer to launchGermany’s federal joint committee (G-BA) is scrutinising Glybera (alipogene tiparvovec), a treatment for the rare genetic condition lipoprotein Share XFirst gene therapy for Europe moves closer to launchhttps://pharmaphorum.com/news/first-gene-therapy-for-europe-moves-closer-to-launch/
Price cut secures NICE nod for GazyvaroRoche’s new treatment for chronic lymphocytic leukaemia (CLL) looks set for NICE approval after the company offered a Share XPrice cut secures NICE nod for Gazyvarohttps://pharmaphorum.com/news/price-cut-secures-nice-nod-for-gazyvaro/
World’s first artificial enzymes created using synthetic biologyUK-based scientists have created the world’s first enzymes made from artificial genetic material. The breakthrough work conducted by Share XWorld’s first artificial enzymes created using synthetic biologyhttps://pharmaphorum.com/news/worlds-first-artificial-enzymes-created-using-synthetic-biology/
Extra billions will only ‘keep the wolf from the door’ for NHSThe UK’s national health service is to receive an extra £2 billion in funding next year – but Share XExtra billions will only ‘keep the wolf from the door’ for NHShttps://pharmaphorum.com/news/extra-billions-will-only-keep-the-wolf-from-the-door-for-nhs/
AZ and Lilly initiate pivotal early Alzheimer’s disease trialAstraZeneca (AZ) and Eli Lilly have started AMARANTH, a phase II/III study investigating a potential treatment for early Share XAZ and Lilly initiate pivotal early Alzheimer’s disease trialhttps://pharmaphorum.com/news/az-and-lilly-initiate-pivotal-early-alzheimer-s-disease-trial/
Breast cancer vaccine delays progression in trialA vaccine that could be used in up to 80 per cent of all cases of breast cancer Share XBreast cancer vaccine delays progression in trialhttps://pharmaphorum.com/news/breast-cancer-vaccine-delays-progression-in-trial/
Boehringer gets EU nod for nintedanib in lung cancerBoehringer Ingelheim’s nintedanib has been cleared in the EU to treat lung cancer, just a few weeks after Share XBoehringer gets EU nod for nintedanib in lung cancerhttps://pharmaphorum.com/news/boehringer-gets-eu-nod-for-nintedanib-in-lung-cancer/
Positive early results for GSK/NIAID Ebola vaccineA phase I trial on an experimental vaccine to prevent Ebola virus disease show it was well-tolerated and Share XPositive early results for GSK/NIAID Ebola vaccinehttps://pharmaphorum.com/news/positive-early-results-for-gskniaid-ebola-vaccine/
UK government launches mental health taskforceFollowing the October announcement that £120 million is to be invested in mental health services, a new mental Share XUK government launches mental health taskforcehttps://pharmaphorum.com/news/uk-government-launches-mental-health-taskforce/
